Navigation Links
Kendle to Ring Opening Bell at NASDAQ Stock Market on August 22
Date:8/20/2007

Opening Bell Ceremony Marks Kendle's 10th Anniversary as Public Company

CINCINNATI, Aug. 20 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization, today announced Chairman and CEO Candace Kendle, PharmD, will ring the opening bell at the NASDAQ Stock Market on Aug. 22, 2007, the company's 10th anniversary as a publicly-traded company. The Opening Bell ceremony will take place at 9:30 a.m. Eastern Time at the NASDAQ MarketSite(R) in New York's Times Square and will be broadcast live on http://www.nasdaq.com and on the seven-story NASDAQ tower, the largest stationary video screen in the world.

(Logo: http://www.newscom.com/cgi-bin/prnh/20030429/KNDLLOGO )

NASDAQ Opening Bell Ceremony - Webcam Instructions

To view the NASDAQ Opening Bell ceremony, go to http://www.kendle.com or http://www.nasdaq.com/about/marketsitetowervideo.asx. Please note:

-- Viewers must have Windows Media Player to view the webcam (Windows

Media Player is downloadable at no charge from

http://www.microsoft.com/windows/windowsmedia/default.aspx).

-- It is recommended viewers download the webcam at 9:15 a.m. so there is

time to troubleshoot in the event of technical difficulties

-- Prior to 9:20 a.m., the webcam will show the Tower; at 9:20 a.m. the

router will be switched and viewers will see inside the MarketSite

studio where the ceremony will take place

-- Viewers should not be alarmed that the webcam is fuzzy. Clarity is

dependent on Internet hook up.

NASDAQ Opening Bell Ceremony - Satellite Feed Information

The opening bell is available from 9:20 a.m. to 9:35 a.m. on uplink IA6 C band / transponder 24, downlink frequency 4180 horizontal. The feed can also be found on Waterfront fiber 1623. For questions, please contact Jolene Libretto at NASDAQ at (646) 441-5220.

About Kendle

Kendle International Inc. (Nasdaq: KNDL) is among the world's leading global clinical research organizations and is the fourth-largest provider of Phase II-IV clinical development services worldwide. We deliver innovative and robust clinical development solutions - from first-in-human studies through market launch and surveillance - to help the world's biopharmaceutical companies maximize product life cycles and grow market share.

Our global clinical development business is focused on five regions - North America, Europe, Asia/Pacific, Latin America and Africa - to meet customer needs. With the expertise of our more than 3,000 associates worldwide, Kendle has conducted clinical trials and provided regulatory and pharmacovigilance services in more than 80 countries. The company was named the "Top CRO to Work With" in the Thomson CenterWatch 2007 Survey of U.S. Investigative Sites. Additional information and investor kits are available upon request from Kendle, 441 Vine Street, Suite 1200, Cincinnati, OH 45202 or from the Company's Web site at http://www.kendle.com.


'/>"/>
SOURCE Kendle

Copyright©2007 PR Newswire.

Related biology technology :

1. Merge files financial reports by market opening
2. NASDAQ will continue to list Merge
3. NASDAQ grants Merge more time for compliance
4. NASDAQ will continue to list Merge
5. No word on NASDAQ extension for Merge
6. NASDAQ puts Merge on notice again
7. Midwest life science stocks kept sizzling in Q2
8. Madisons PunchStock acquired by Getty Images
9. Midwest life science stocks sizzle in a tepid first quarter
10. Sonic Foundry completes $11.25M stock offer
11. Sonic Foundry sets $3.75 stock price
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... ... July 20, 2017 , ... Litmus Health ... announced its full advisory board. The board comprises leaders spanning business, technology, academia, ... PhD, former VP of Engineering, to Chief Technology Officer. Crooks will lead strategy ...
(Date:7/20/2017)... and PLYMOUTH, Minn., July 20, 2017   KCNQ2 ... personalized genetic evaluations company, today announced that they ... investigating a genetic mutation implicated in KCNQ2 epileptic ... partnership for a second case involving an additional ... KCNQ2 Cure Alliance and Pairnomix entered into a ...
(Date:7/18/2017)... ... July 18, 2017 , ... ... and biotherapeutics development, announces the launch of a new NTA biosensor chip for ... researchers to study the kinetics of polyhistidine-tagged (His-tagged) molecules quickly and reliably. ...
(Date:7/18/2017)... , ... July 18, 2017 , ... ... the United States Patent and Trademark Office for its Patent Applications 14/858,857 and ... Office’s allowances of these patent applications further expand the protection of G-CON’s R&D ...
Breaking Biology Technology:
(Date:6/23/2017)... and ITHACA, N.Y. , ... and Cornell University, a leader in dairy research, today ... bioinformatics designed to help reduce the chances that the ... the onset of this dairy project, Cornell University has ... for Sequencing the Food Supply Chain, a food safety ...
(Date:5/16/2017)... 16, 2017  Veratad Technologies, LLC ( www.veratad.com ), ... and identity verification solutions, announced today they will participate ... May 15 thru May 17, 2017, in ... Trade Center. Identity impacts the lives ... today,s quickly evolving digital world, defining identity is critical ...
(Date:4/24/2017)... 2017 Janice Kephart , former ... Strategy Partners, LLP (IdSP) , today issues the ... Trump,s March 6, 2017 Executive Order: Protecting ... can be instilled with greater confidence, enabling the ... refugee applications are suspended by until at least ...
Breaking Biology News(10 mins):